Body composition and weight gain in new users of the three-monthly injectable contraceptive, depot-medroxyprogesterone acetate, after 12 months of follow-up

European Journal of Contraception and Reproductive Health Care

Volumn 19, Issue 6, 2014, Pages 432-438

  Dos Santos, Priscilla De Nazaré Silva ^a   Modesto, Waleska Oliveira ^a   Dal'Ava, Nathalia ^a   Bahamondes, Maria Valéria ^a   Pavin, Elizabeth João ^a   Fernandes, Arlete Maria Dos Santos ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Body composition; Contraception; Depot medroxyprogesterone acetate; Weight

Indexed keywords

ALCOHOL; INJECTABLE CONTRACEPTIVE AGENT; MEDROXYPROGESTERONE ACETATE; CONTRACEPTIVE AGENT;

ADULT; ARTICLE; BODY COMPOSITION; BODY MASS; BODY WEIGHT; COHORT ANALYSIS; COPPER INTRAUTERINE DEVICE; DEMOGRAPHY; DRUG USE; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FOLLOW UP; HABIT; HEALTH CARE PERSONNEL; HIP CIRCUMFERENCE; HUMAN; LIFESTYLE; LIPID STORAGE; SKINFOLD THICKNESS; SMOKING; SOCIAL ASPECT; WAIST HIP RATIO; WEIGHT GAIN; ADOLESCENT; ADVERSE EFFECTS; DRUG EFFECTS; INJECTION; INTRAUTERINE CONTRACEPTIVE DEVICE; YOUNG ADULT;

ADOLESCENT; ADULT; BODY COMPOSITION; BODY MASS INDEX; CONTRACEPTIVE AGENTS, FEMALE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INJECTIONS; INTRAUTERINE DEVICES; MEDROXYPROGESTERONE ACETATE; WEIGHT GAIN; YOUNG ADULT;

EID: 84911121632     PISSN: 13625187     EISSN: 14730782     Source Type: Journal    
DOI: 10.3109/13625187.2014.936934     Document Type: Article

References (21)

1. Fraser IS, Weisberg E. A comprehensive review of injectable contraception with special emphasis on depot medroxyprogesterone acetate. Med J Aust 1981;1(1 Suppl.):3-19.
2. Mosher WD, Martinez GM, Chandra A, et al. Use of contraception and use of family planning services in the United States: 1982-2002. Advance data from vital and health statistics; No. 350. Hyattsville, MD: National Center for Health Statistics 2004:1-36.
3. Bakry S, Merhi ZO, Scalise TJ, et al. Depot-medroxyprogesterone acetate: An update. Arch Gynecol Obstet 2008;278:1-12.
4. Pelkman C. Hormones and weight change. J Reprod Med 2002;47:791-4.
5. Taneepanichskul S, Reinprayoon D, Khaosaad P. Comparative study of weight change between long-term DMPA and IUD acceptors. Contraception 1998;58:149-51.
6. Clark M K, Dillon J S, Sowers M, et al. Weight, fat mass, and central distribution of fat increase when women use depot-medroxyprogesterone acetate for contraception. Int J Obes 2005;29:1252-8.
7. Westhoff C, Jain JK, Milsom I, et al. Changes in weight with depot medroxyprogesterone acetate subcutaneous injection 104 mg/0.65 mL. Contraception 2007;75:261-7.
8. Berenson A B, Rahman M. Changes in weight, total fat, percent body fat, and central-to-peripheral fat ratio associated with injectable and oral contraceptive use. Am J Obstet Gynecol 2009;200:329. e1-8.
9. Le YC, Rahman M, Berenson A B. Early weight gain predicting later weight gain among depot medroxyprogesterone acetate users. Obstet Gynecol 2009;114:279-84.
10. Friendly M. SAS system for statistical graphics, version 1.2, 1st edn. Cary, NC: SAS Institute Inc. 1995. Accessed 18 April 2014 from: http://euclid.psych.yorku.ca/SCS/sasmac/ or http://euclid.psych.yorku.ca/SCS/sasmac/fpower.html
11. ABEP. [Brazilian Association of Research Companies]. Critério de classificac¸ão econômica Brasil [The Brazilian economic classification criteria]. 2010. Accessed 18 April 2014 from: http://www.abep.org/novo/Utils/FileGenerate.ashx?id=46
12. Ford E S, Kohl HW 3rd, Mokdad AH, et al. Sedentary behavior, physical activity, and the metabolic syndrome among U.S. adults. Obes Res 2005;13:608-14.
13. Lohman TG, Roche A F, Martorell R. Anthropometric standardization reference manual, 1st edn. Champaign, IL: Human Kinetics Books 1991.
14. World Health Organization. Physical status: The use and interpretation of anthropometry. (Technical Report Series, n.854). Geneva: World Health Organization 1995. Accessed 18 April 2014 from: http://whqlibdoc.who.int/trs/WHO-TRS-854.pdf?ua=1
15. Faulkner JA. Physiology of swimming and diving. In: Falls H, ed. Exercise physiology. Baltimore: Academic Press 1968:415-46.
16. Amatayakul K, Sivasomboon B, Thanangkul O. A study of the mechanism of weight gain in medroxyprogesterone acetate users. Contraception 1980;22:605-22.
17. Vickery Z, Madden T, Zhao Q, et al. Weight change at 12 months in users of three progestin-only contraceptive methods. Contraception 2013;88:503-8.
18. Pantoja M, Medeiros T, Baccarin MC, et al. Variations in body mass index of users of depot-medroxyprogesterone acetate as a contraceptive. Contraception 2010;81:107-11.
19. Bonny A E, Ziegler J, Harvey R, et al. Weight gain in obese and nonobese adolescent girls initiating depot medroxyprogesterone, oral contraceptive pills, or no hormonal contraceptive method. Arch Pediatr Adolesc Med 2006;160:40-5.
20. Bonny A E, Lange H L, Rogers L K, et al. A pilot study of depot medroxyprogesterone acetate pharmacokinetics and weight gain in adolescent females. Contraception 2014;89:357-60.
21. Haider S, Darney PD. Injectable contraception. Clin Obstet Gynecol 2007;50:898-906.